| Inhibition of the mTORC pathway in the antiphospholipid syndrome G Canaud, F Bienaimé, F Tabarin, G Bataillon, D Seilhean, LH Noël, ... New England Journal of Medicine 371 (4), 303-312, 2014 | 383 | 2014 |
| Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology E Teyssou, T Takeda, V Lebon, S Boillée, B Doukouré, G Bataillon, ... Acta neuropathologica 125, 511-522, 2013 | 278 | 2013 |
| Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy JH Park, SF Jonas, G Bataillon, C Criscitiello, R Salgado, S Loi, G Viale, ... Annals of oncology 30 (12), 1941-1949, 2019 | 233 | 2019 |
| Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer J Ogier du Terrail, A Leopold, C Joly, C Béguier, M Andreux, C Maussion, ... Nature medicine 29 (1), 135-146, 2023 | 115 | 2023 |
| ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics N Kiavue, L Cabel, S Melaabi, G Bataillon, C Callens, F Lerebours, ... Oncogene 39 (3), 487-502, 2020 | 109 | 2020 |
| Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site M Kamal, S Lameiras, M Deloger, A Morel, S Vacher, C Lecerf, C Dupain, ... British journal of cancer 124 (4), 777-785, 2021 | 81 | 2021 |
| Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer E Jeannot, A Latouche, C Bonneau, MA Calméjane, C Beaufort, ... Clinical Cancer Research 27 (21), 5869-5877, 2021 | 72 | 2021 |
| Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies J Sandbank, G Bataillon, A Nudelman, I Krasnitsky, R Mikulinsky, L Bien, ... NPJ Breast Cancer 8 (1), 129, 2022 | 65 | 2022 |
| High-accuracy determination of microsatellite instability compatible with liquid biopsies AB Silveira, FC Bidard, A Kasperek, S Melaabi, ML Tanguy, M Rodrigues, ... Clinical Chemistry 66 (4), 606-613, 2020 | 58 | 2020 |
| Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images T Lazard, G Bataillon, P Naylor, T Popova, FC Bidard, D Stoppa-Lyonnet, ... Cell Reports Medicine 3 (12), 2022 | 54 | 2022 |
| Tumor-infiltrating lymphocytes in triple-negative breast cancer RA Leon-Ferre, SF Jonas, R Salgado, S Loi, V De Jong, JM Carter, ... JAMA 331 (13), 1135-1144, 2024 | 49 | 2024 |
| HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer L Cabel, C Bonneau, A Bernard-Tessier, D Héquet, C Tran-Perennou, ... ESMO open 6 (3), 100154, 2021 | 49 | 2021 |
| Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie C Basse, C Morel, M Alt, MP Sablin, C Franck, G Pierron, C Callens, ... ESMO open 3 (3), e000339, 2018 | 49 | 2018 |
| Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers AL Renault, N Mebirouk, L Fuhrmann, G Bataillon, E Cavaciuti, D Le Gal, ... Breast Cancer Research 20, 1-18, 2018 | 48 | 2018 |
| Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts F Coussy, M Lavigne, L De Koning, R El Botty, F Nemati, A Naguez, ... Theranostics 10 (4), 1531, 2020 | 46 | 2020 |
| High rate of PIK3CA mutations but no TP53 mutations in low‐grade adenosquamous carcinoma of the breast G Bataillon, L Fuhrmann, E Girard, E Menet, M Laé, M Capovilla, ... Histopathology 73 (2), 273-283, 2018 | 44 | 2018 |
| Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: a systematic review and case report analysis C Le Page, K Rahimi, M Rodrigues, V Heinzelmann-Schwarz, N Recio, ... Gynecologic oncology 156 (2), 377-386, 2020 | 24 | 2020 |
| HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports A Arfi, D Hequet, G Bataillon, C Tran-Perennou, F Farkhondeh, ... BMC cancer 19, 1-6, 2019 | 20 | 2019 |
| Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with … B Grandal, C Evrevin, E Laas, I Jardin, S Rozette, L Laot, E Dumas, ... Cancers 12 (12), 3681, 2020 | 19 | 2020 |
| Disseminated tumor cells predict efficacy of regional nodal irradiation in early stage breast cancer F Mignot, D Loirat, S Dureau, G Bataillon, M Caly, A Vincent-Salomon, ... International Journal of Radiation Oncology* Biology* Physics 103 (2), 389-396, 2019 | 17 | 2019 |
